The aim of this study was to map the spectrum of microorganisms belonging to the genus Acinetobacter in domestic animals with a specific focus on the prevalence of Acinetobacter pseudolwoffii. Additionally, the susceptibility of isolates to antimicrobial agents was determined. In the period from January 1, 2014, to August 31, 2015, a total of 9 544 samples originating from gross lesions and pathological processes of animals exhibiting clinical symptoms of the disease were examined across 41 districts in the Czech Republic. The examinations were carried out using culture methods involving meat-peptone blood agar and Endo agar under aerobic conditions at a temperature of 37 ± 1 °C for 18-24 hours. Isolates were confirmed using molecular phenotypic method MALDI-TOF MS with the MBT Compass Library Revision L 2020 covering 3 239 species/entries (9 607 MSP) from Bruker Daltonics company. Out of the 108 isolates (prevalence 1.13%), 14 species of Acinetobacter spp. were identified, with 5 isolates remaining unclassified as species. A. pseudolwoffii was the predominant species isolated in 25 cases (prevalence 0.26%). Antimicrobial susceptibility was determined for 12 antimicrobials by the disc diffusion method, with A. pseudolwoffii isolates exhibiting the lowest susceptibility to ceftazidime (32%) and co-trimoxazole (60%).

Department of Infectious Diseases and Preventive Medicine Veterinary Research Institute Brno Czech Republic

Ptacy s r o Valasska Bystrice Czech Republic

Science and Research Centre Faculty of Health Sciences Palacky University Olomouc Olomouc Czech Republic

Zobrazit více v PubMed

Almasaudi SB. Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features. Saudi J Biol Sci. 2018 Mar;25(3):586-96. PubMed PMC

Bergogne-Berezin E, Friedman H, Bendinelli M. Acinetobacter: Biology and pathogenesis. New York, USA: Springer Science and Business Media New York; 2008. 220 p.

Bzdil J, Holy O, Toporcak J. Gram-negative aerobic and microaerophilic microorganisms isolated from pathological processes and lesions of horses. Vet Med-Czech. 2018 Feb 28;63(2):55-62.

CLSI – Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. CLSI supplement M100. 30th ed. Wayne, Pensylvania, USA: Clinical and Laboratory Standards Institute; 2020. 294 p.

Euzeby JP. List of procaryotic names with standing in nomenclature [Internet]. Braunschweig, Germany: Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures GmbH. 2023. [cited 2023 Jan 25]. Available from: http://lpsn.dsmz.de.

Francey T, Gaschen F, Nicolet J, Burnens AP. The role of Acinetobacter baumannii as a nosocomial pathogen for dogs and cats in an intensive care unit. J Vet Intern Med. 2000 Mar-Apr;14(2):177-83. PubMed

Gentilini F, Turba ME, Pasquali F, Mion D, Romagnoli N, Zambon E, Terni D, Peirano G, Pitout JDD, Parisi A, Sambri V, Zanoni RG. Hospitalized pets as a source of carbapenem-resistance. Front Microbiol. 2018 Dec 6;9:2872. PubMed PMC

Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother. 2006 Dec;50(12):4114-23. PubMed PMC

Jokisalo J, Bryan J, Legget B, Abbott Y, Katz LM. Multiple-drug resistant Acinetobacter baumannii bronchopneumonia in a colt following intensive care treatment. Equine Vet Educ. 2010 May 18;22(6):281-6.

Kimura Y, Miyamoto T, Aoki K, Ishii Y, Harada K, Watarai M, Hatoya S. Analysis of IMP-1 type metallo-β-lactamase-producing Acinetobacter radioresistens isolated from companion animals. J Infect Chemother. 2017 Sep;23(9):655-7. PubMed

Kurcik-Trajkovska B. Acinetobacter spp. – A serious enemy threatening hospitals worldwide. Maced J Med Sci. 2009 Jun 1;2(2):157-62.

Kuzi S, Blum SE, Kahane N, Adler A, Hussein O, Segev G, Aroch I. Multi-drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex infection outbreak in dogs and cats in a veterinary hospital. J Small Anim Pract. 2016 Nov;57(11):617-25. PubMed

Nemec A, Musilek M, Sedo O, De Baere T, Maixnerova M, van der Reijden TJK, Zdrahal Z, Vaneechoutte M, Dijkshoorn L. Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acine-tobacter genomic species 10 and 11, respectively. Int J Syst Evol Microbiol. 2010 Apr 1;60(4):896-903. PubMed

Nemec A, Dijkshoorn L, Cleenwerck I, De Baere T, Janssens D, van der Reijden TJK, Jezek P, Vaneechoutte M. Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimens. Int J Syst Evol Microbiol. 2003 Sep;53(Pt 5):1563-7. PubMed

Nemec A, Krizova L, Maixnerova M, Sedo O, Brisse S, Higgins PG. Acinetobacter seifertii sp. nov., a member of the Acinetobacter calcoaceticus – Acinetobacter baumannii complex isolated from human clinical specimens. Int J Syst Evol Microbiol. 2015 Mar 1;65(3):934-42. PubMed

Nemec A, Radolfova-Krizova L, Maixnerova M, Vrestiakova E, Jezek P, Sedo O. Taxonomy of haemolytic and/or proteolytic strains of the genus Acinetobacter with the proposal of Acinetobacter courvalinii sp. nov. (genomic species 14 sensu Bouvet and Jeanjean), Acinetobacter dispersus sp. nov. (genomic species 17), Acinetobacter modestus sp. nov., Acinetobacter proteolyticus sp. nov. and Acinetobacter vivianii sp. nov. Int J Syst Evol Microbiol. 2016 Apr 1;66(4):1673-85. PubMed

Nemec A, Radolfova-Krizova L, Maixnerova M, Nemec M, Clermont D, Bzdil J, Jezek P, Spanelova P. Revising the taxonomy of the Acinetobacter lwoffii group: The description of Acinetobacter pseudolwoffii sp. nov. and emended description of Acinetobacter lwoffii. Syst Appl Microbiol. 2019 Mar;42(2):159-67. PubMed

Nemec A. Vyuziti diskoveho difuzniho testu v epidemiologicke typizaci multirezistentnich kmenu Acinetobacter baumanni [Using of disc diffusion test for epidemiological typing of multiresistant Acinetobacter baumannii strains]. Klin Mikrobiol Infekc Lek. 1999;5(9-10):287-97. Czech.

Queenan AM, Pillar CM, Deane J, Sahm DF, Lynch AS, Flamm RK, Peterson J, Davies TA. Multidrug resistance among Acinetobacter spp. in the USA and activity profile of key agents: Results from CAPITAL Surveillance 2010. Diagn Microbiol Infect Dis. 2012 Jul;73(3):267-70. PubMed

Samkange A, van der Westhuizen J, Voigts AS, Chitate F, Kaatura I, Khaiseb S, Hikufe EH, Kabajani J, Bishi AS, Mbiri P, Hawanga NN, Mushonga B. Investigation of the outbreaks of abortions and orchitis in livestock in Namibia during 2016–2018. Trop Anim Health Prod. 2022 Oct 15;54(6):346. PubMed

Tavakol M, Momtaz H, Mohajeri P, Shokoohizadeh L, Tajbakhsh E. Genotyping and distribution of putative virulence factors and antibiotic resistance genes of Acinetobacter baumannii strains isolated from raw meat. Antimicrob Resist Infect Control. 2018 Oct 4;7:120. PubMed PMC

Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol. 2006 Aug;44(8):2974-6. PubMed PMC